IMUX•benzinga•
Immunic, Announces Pricing Of $5.1M Registered Direct Offering At $0.90 Per Share Led by Aberdeen Investments
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 9, 2025 by benzinga